Teesside University academic wins £100,000 grant for cancer research

Press/Media: Press / Media

Description

Sharel has been awarded £100,000 to fund essential brain cancer research which aims to advance diagnosis and treatments.

Sharel won the grant from the Academy of Medical Sciences as part of the highly competitive Springboard Award. 

Sharel will use this funding to explore the nanoscale electrochemistry of brain cancer cells.

Using a multifunctional nanoscale electrochemical imaging platform, Sharel will be able to take a closer look at brain tumour cells and their processes to gain a better understanding of their biology.

The technology uses tiny electrodes to gain an extremely close and detailed visualisation of the biology of living cells and will allow Sharel to explore how brain cancer reacts to different therapies on a cellular level.

This research will be applied to improving or designing more effective treatments for cancer patients.

Sharel has been invited on BBC Radio Tees for an interview to discuss her research (6th April 2022).

It is available to listen to here…

https://www.bbc.co.uk/sounds/play/p0bv951t from 1:51:40.

Period31 Mar 2022 → 6 Apr 2022

Media contributions

2

Media contributions

  • TitleBBC Tees Interview
    Degree of recognitionNational
    Media name/outletBBE Tees
    Media typeRadio
    Country/TerritoryUnited Kingdom
    Date6/04/22
    DescriptionSharel has been invited on BBC Radio Tees for an interview to discuss her research (6th April 2022).
    URLhttps://www.bbc.co.uk/sounds/play/p0bv951t
    PersonsPei San (Sharel) E
  • TitleBrain cancer research backed by award
    Degree of recognitionInternational
    Media name/outletNRTIMES
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date31/03/22
    DescriptionPioneering brain cancer research has been backed by a new six-figure award, to support its ambition to advance diagnosis and treatments.

    Dr Sharel Peisan E, a chemistry lecturer at Teesside University, will examine the nanoscale electrochemistry of brain cancer cells.

    Using a multifunctional nanoscale electrochemical imaging platform, Dr E will be able to take a closer look at brain tumour cells and their processes to gain a better understanding of their biology.

    The technology uses tiny electrodes to gain an extremely close and detailed visualisation of the biology of living cells.

    This research project, backed by an award of £100,000, aims to explore how brain cancer reacts to different therapies on a cellular level, which will be applied to improving or designing more effective treatments for cancer patients.

    It will also be able to provide insight into other neurodegenerative diseases such as Alzheimer’s in much the same way.

    “Glioblastoma is one of the most devastating cancers, although its biology remains somewhat of a mystery in cancer research, with brain cancer cells being difficult to analyse using current methods of examination,” explained Dr E, who is based at Teesside University’s National Horizons Centre.

    Dr E won the grant from the Academy of Medical Sciences as part of the Springboard Award, which provides funding and career support for innovative bioscientists.

    Teesside University’s National Horizons Centre, based at the Darlington campus, is a £22.3million centre of excellence for innovation and training in biosciences and healthcare, with strength in cancer research.
    URLhttps://lnkd.in/dXsYyWHC
    PersonsPei San (Sharel) E